{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:29:14Z","timestamp":1793788154362,"version":"4.6.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003953.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000}}],"reference-count":98,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003953.pub4","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:25:51Z","timestamp":1790159151000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antifungal therapy for newborn infants with invasive fungal infection"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4659-760X","authenticated-orcid":false,"given":"Rameshwar","family":"Prasad","sequence":"additional","affiliation":[{"name":"Neonatology; All India Institute of Medical Sciences; Patna India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Habibullah","family":"Sk","sequence":"additional","affiliation":[{"name":"Neonatology; Institute of Post Graduate Medical Education and Research; Kolkata, West Bengal India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Saha","sequence":"additional","affiliation":[{"name":"Neonatology; Institute of Post Graduate Medical Education and Research; Kolkata, West Bengal India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Neonatology; All India Institute of Medical Sciences; Bhubaneswar, Odisha India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Kumar","sequence":"additional","affiliation":[{"name":"Rajendra Institute of Medical Sciences; Ranchi, Jharkhand India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Fiander","sequence":"additional","affiliation":[{"name":"Cochrane Neonatal Group; Vermont Oxford Network; Burlington Vermont USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Cracknell","sequence":"additional","affiliation":[{"name":"Cochrane Neonatal Group; Vermont Oxford Network; Burlington Vermont USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"McGuire","sequence":"additional","affiliation":[{"name":"Centre for Reviews and Dissemination; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"supported by the Cochrane Neonatal Review Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"10.1002\/14651858.CD003953.pub4-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/1471-2334-9-183","article-title":"Characteristics and outcome of infants with candiduria in neonatal intensive care \u2013 a Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study","volume":"9","author":"Robinson","year":"2009","journal-title":"BMC Infectious Diseases"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1145252","DOI":"10.3389\/fped.2023.1145252","article-title":"Fungal infection and neurodevelopmental outcomes at 18\u201330 months in preterm infants","volume":"11","author":"Zhou","year":"2023","journal-title":"Frontiers in Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD003953.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"F188","DOI":"10.1136\/adc.2005.082024","article-title":"Invasive fungal infection in very low birthweight infants: national prospective surveillance study","volume":"91","author":"Clerihew","year":"2006","journal-title":"Archives of Disease in Childhood. Fetal and Neonatal Edition"},{"issue":"6","key":"10.1002\/14651858.CD003953.pub4-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"e2022058813","DOI":"10.1542\/peds.2022-058813","article-title":"Late-onset sepsis among very preterm infants","volume":"150","author":"Flannery","year":"2022","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD003953.pub4-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pedneo.2024.01.006","article-title":"Early- and late-onset candidemia in very low birth weight infants in the Korean neonatal network, 2013-2017","volume":"66","author":"Jung","year":"2025","journal-title":"Pediatrics and Neonatology"},{"issue":"5","key":"10.1002\/14651858.CD003953.pub4-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"e2023062223","DOI":"10.1542\/peds.2023-062223","article-title":"Late-onset sepsis in very low birth weight infants","volume":"152","author":"Klinger","year":"2023","journal-title":"Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD003953.pub4-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1542\/peds.2013-0671","article-title":"Changes in the incidence of candidiasis in neonatal intensive care units","volume":"133","author":"Aliaga","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"e865","DOI":"10.1542\/peds.2009-3412","article-title":"Neonatal candidiasis: epidemiology, risk factors, and clinical judgment","volume":"126","author":"Stoll","year":"2010","journal-title":"Pediatrics"},{"issue":"8","key":"10.1002\/14651858.CD003953.pub4-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/INF.0000000000001570","article-title":"Late-onset sepsis in extremely premature infants: 2000-2011","volume":"36","author":"Greenberg","year":"2017","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"11","key":"10.1002\/14651858.CD003953.pub4-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/INF.0000000000001968","article-title":"Invasive fungal infections in neonates in Canada: epidemiology and outcomes","volume":"37","author":"Ting","year":"2018","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"1","key":"10.1002\/14651858.CD003953.pub4-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/1471-2334-14-327","article-title":"Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls","volume":"14","author":"Barton","year":"2014","journal-title":"BMC Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD003953.pub4-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1542\/peds.2004-2292","article-title":"Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months","volume":"117","author":"Stoll","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD003953.pub4-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1542\/peds.2008-2055","article-title":"Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients","volume":"123","author":"Blyth","year":"2009","journal-title":"Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00006454-200004000-00011","article-title":"Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey Study Group","volume":"19","author":"Saiman","year":"2000","journal-title":"Pediatric Infectious Diseases Journal"},{"issue":"2","key":"10.1002\/14651858.CD003953.pub4-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jnn.2021.08.013","article-title":"Risk factors for candidemia in neonates: systematic review and meta-analysis","volume":"28","author":"Sousa","year":"2022","journal-title":"Journal of Neonatal Nursing"},{"issue":"3","key":"10.1002\/14651858.CD003953.pub4-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1093\/jpids\/piy009","article-title":"Neonatal and pediatric candidemia: results from population-based active laboratory surveillance in four US locations, 2009\u20132015","volume":"7","author":"Benedict","year":"2018","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"issue":"1","key":"10.1002\/14651858.CD003953.pub4-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1542\/peds.2011-3620","article-title":"Trends in candida central line-associated bloodstream infections among NICUs, 1999-2009","volume":"130","author":"Chitnis","year":"2012","journal-title":"Pediatrics"},{"issue":"7","key":"10.1002\/14651858.CD003953.pub4-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofaf329","article-title":"The burden of neonatal invasive candidiasis in low- and middle-income countries: a systematic review and meta-analysis","volume":"12","author":"Tsai","year":"2025","journal-title":"Open Forum Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD003953.pub4-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"myad010","DOI":"10.1093\/mmy\/myad010","article-title":"Neonatal invasive candidiasis in low- and middle-income countries: data from the NeoOBS study","volume":"61","author":"Cook","year":"2023","journal-title":"Medical Mycology: official publication of the International Society for Human and Animal Mycology"},{"issue":"6","key":"10.1002\/14651858.CD003953.pub4-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"e0180705","DOI":"10.1371\/journal.pone.0180705","article-title":"Alarming rates of antimicrobial resistance and fungal sepsis in outborn neonates in North India","volume":"13","author":"Jajoo","year":"2018","journal-title":"PLOS One"},{"issue":"11","key":"10.1002\/14651858.CD003953.pub4-BIB0021|cit21","first-page":"830","article-title":"Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants","volume":"44","author":"Parikh","year":"2007","journal-title":"Indian Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD003953.pub4-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"001968","DOI":"10.1099\/jmm.0.001968","article-title":"Epidemiology and management of infections in critically ill neonates: findings from a cohort study in a Brazilian neonatal intensive care unit","volume":"74","author":"Ferreira","year":"2025","journal-title":"Journal of Medical Microbiology"},{"issue":"5","key":"10.1002\/14651858.CD003953.pub4-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.pedneo.2021.05.011","article-title":"Late-onset sepsis in very low birth weight preterm infants: 7 years' experience at a tertiary hospital in China","volume":"62","author":"Ma","year":"2021","journal-title":"Pediatrics and Neonatology"},{"issue":"5","key":"10.1002\/14651858.CD003953.pub4-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD003953.pub4-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/myc.13053","article-title":"Epidemiological features of nosocomial candidaemia in neonates, infants and children: a multicentre study in Iran","volume":"63","author":"Ahangarkani","year":"2020","journal-title":"Mycoses"},{"issue":"3","key":"10.1002\/14651858.CD003953.pub4-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1442-200X.2012.03574.x","article-title":"Neonatal candidiasis: results of an 8 year study","volume":"54","author":"Celebi","year":"2012","journal-title":"Pediatrics International: official publication of the Japan Pediatric Society"},{"issue":"8","key":"10.1002\/14651858.CD003953.pub4-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/INF.0000000000003151","article-title":"Epidemiology of culture-confirmed candidemia among hospitalized children in South Africa, 2012-2017","volume":"40","author":"Shuping","year":"2021","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11046-011-9498-3","article-title":"Neonatal intensive care unit candidemia: epidemiology, risk factors, outcome, and critical review of published case series","volume":"173","author":"Spiliopoulou","year":"2012","journal-title":"Mycopathologia"},{"issue":"5","key":"10.1002\/14651858.CD003953.pub4-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"884","DOI":"10.3390\/antibiotics12050884","article-title":"Antifungals: from pharmacokinetics to clinical practice","volume":"12","author":"Carmo","year":"2023","journal-title":"Antibiotics"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"813871","DOI":"10.1155\/2011\/813871","article-title":"Outcomes of neonatal candidiasis: the impact of delayed initiation of antifungal therapy","volume":"2011","author":"Cahan","year":"2011","journal-title":"International Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD003953.pub4-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006343.pub2","article-title":"Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections","author":"Blyth","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD003953.pub4-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010481.pub2","article-title":"Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function","author":"Botero Aguirre","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD003953.pub4-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000969.pub2","article-title":"Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia","author":"Johansen","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003953.pub4-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/myc.12585","article-title":"Efficacy and safety of amphotericin B lipid-based formulations \u2013 a systematic review and meta-analysis","volume":"60","author":"Steimbach","year":"2017","journal-title":"Mycoses"},{"issue":"12","key":"10.1002\/14651858.CD003953.pub4-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/jphp.12802","article-title":"Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis","volume":"69","author":"Tonin","year":"2017","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"5","key":"10.1002\/14651858.CD003953.pub4-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/INF.0b013e3182467a72","article-title":"Antifungal therapy and outcomes in infants with invasive Candida infections","volume":"31","author":"Ascher","year":"2012","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"9","key":"10.1002\/14651858.CD003953.pub4-BIB0039|cit39","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002033.pub2","article-title":"Nystatin prophylaxis and treatment in severely immunodepressed patients","author":"Gotzsche","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD003953.pub4-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"4808","DOI":"10.1128\/AAC.48.12.4808-4812.2004","article-title":"Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B","volume":"48","author":"Offner","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"114969","DOI":"10.1016\/j.addr.2023.114969","article-title":"Reviving the interest in the versatile drug nystatin: a multitude of strategies to increase its potential as an effective and safe antifungal agent","volume":"199","author":"Sousa","year":"2023","journal-title":"Advanced Drug Delivery Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1440-1754.1992.tb02678.x","article-title":"Itraconazole therapy for disseminated candidiasis in a very low birthweight neonate","volume":"28","author":"Bhandari","year":"1992","journal-title":"Journal of Paediatrics and Child Health"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12519-016-0034-x","article-title":"Efficacy and safety of itraconazole use in infants","volume":"12","author":"Chen","year":"2016","journal-title":"World Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/inf.0000000000002554","article-title":"Rhizopus infection in a preterm infant: a novel use of posaconazole","volume":"39","author":"Fatemizadeh","year":"2020","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"5","key":"10.1002\/14651858.CD003953.pub4-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1046\/j.1439-0507.2001.00649.x","article-title":"Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis","volume":"44","author":"Kontoyiannis","year":"2001","journal-title":"Mycoses"},{"issue":"5","key":"10.1002\/14651858.CD003953.pub4-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/jpids\/piy119","article-title":"Posaconazole administration in hospitalized children in the United States","volume":"8","author":"Lavigne","year":"2019","journal-title":"Journal of the Pediatric Infectious Diseases Society"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"204209862211432","DOI":"10.1177\/20420986221143266","article-title":"Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS","volume":"13","author":"Chai","year":"2022","journal-title":"Therapeutic Advances in Drug Safety"},{"issue":"11","key":"10.1002\/14651858.CD003953.pub4-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/00006454-199811000-00010","article-title":"Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis","volume":"17","author":"Huttova","year":"1998","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"8759","key":"10.1002\/14651858.CD003953.pub4-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0140-6736(91)90112-3","article-title":"Stevens-Johnson syndrome after fluconazole","volume":"338","author":"Gussenhoven","year":"1991","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD003953.pub4-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1542\/peds.107.2.404","article-title":"Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time","volume":"107","author":"Neely","year":"2001","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp","volume":"18 Suppl 7","author":"Hope","year":"2012","journal-title":"Clinical Microbiology and Infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD003953.pub4-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2165\/11585270-000000000-00000","article-title":"Echinocandin antifungal drugs in fungal infections: a comparison","volume":"71","author":"Chen","year":"2011","journal-title":"Drugs"},{"issue":"10","key":"10.1002\/14651858.CD003953.pub4-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1345\/aph.1M237","article-title":"Echinocandins: the newest class of antifungals","volume":"43","author":"Sucher","year":"2009","journal-title":"Annals of Pharmacotherapy"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/jp.2008.197","article-title":"Hepatitis associated with micafungin use in a preterm infant","volume":"29","author":"King","year":"2009","journal-title":"Journal of Perinatology"},{"issue":"12","key":"10.1002\/14651858.CD003953.pub4-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/01.inf.0000245103.07614.e1","article-title":"The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants","volume":"25","author":"Heresi","year":"2006","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0056|cit56","unstructured":"European Medicines Agency (EMA). Annex 1. Summary of product characteristics https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/mycamine-epar-product-information_en.pdf"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0057|cit57","unstructured":"Food and Drug Administration (FDA). Supplement approval https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2019\/021506Orig1s023ltr.pdf"},{"issue":"11","key":"10.1002\/14651858.CD003953.pub4-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1097\/inf.0000000000000434","article-title":"Micafungin in premature and non-premature infants","volume":"33","author":"Manzoni","year":"2014","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"5","key":"10.1002\/14651858.CD003953.pub4-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1542\/peds.53.5.748","article-title":"Recovery from disseminated candidiasis in a premature neonate","volume":"53","author":"Hill","year":"1974","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD003953.pub4-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0732-8893(01)00297-8","article-title":"Evaluation of amphotericin B and flucytosine in combination against Candida albicans and Cryptococcus neoformans using time-kill methodology","volume":"41","author":"Keele","year":"2001","journal-title":"Diagnostic Microbiology and Infectious Disease"},{"issue":"9","key":"10.1002\/14651858.CD003953.pub4-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1128\/AAC.46.9.2982-2989.2002","article-title":"In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach","volume":"46","author":"Te Dorsthorst","year":"2002","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"10.1002\/14651858.CD003953.pub4-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000007260","article-title":"Flucytosine: correlation between toxicity and pharmacokinetic parameters","volume":"46","author":"Vermes","year":"2000","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive fungal diseases in adult patients in intensive care unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003953.pub4-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003953.pub2","article-title":"Systemic antifungal drugs for invasive fungal infection in preterm infants","author":"Clerihew","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD003953.pub4-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003953.pub3","article-title":"Antifungal therapy for newborn infants with invasive fungal infection","author":"Clerihew","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0066|cit66","unstructured":"Cumpston M Lasserson T Flemyng E Page MJ Chapter III: Reporting the review (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0067|cit67","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003953.pub4-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"e2461554","DOI":"10.1001\/jamanetworkopen.2024.61554","article-title":"Proposed core outcomes after neonatal sepsis: a consensus statement","volume":"8","author":"Taneri","year":"2025","journal-title":"JAMA Network Open"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0070|cit70","doi-asserted-by":"crossref","unstructured":"Bayley N Bayley Scales of Infant and Toddler Development, Third Edition; 2005 Available at https:\/\/www.pearsonclinical.co.uk\/en-gb\/Store\/Professional-Assessments\/Behavior\/Adaptive\/Bayley-Scales-of-Infant-and-Toddler-DevelopmentC-Third-Edition\/p\/P100009252 10.1037\/t14978-000","DOI":"10.1037\/t14978-000"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0071|cit71","volume-title":"The Abilities of Babies: a Study in Mental Measurement","author":"Griffiths","year":"1954"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1469-8749.1997.tb07414.x","article-title":"Development and reliability of a system to classify gross motor function in children with cerebral palsy","volume":"39","author":"Palisano","year":"1997","journal-title":"Developmental Medicine and Child Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003953.pub4-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/jrsm.1315","article-title":"Revisiting the need for a literature search narrative: a brief methodological note","volume":"9","author":"Cooper","year":"2018","journal-title":"Research Synthesis Methods"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0074|cit74","unstructured":"Covidence Veritas Health Innovation 2025"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0075|cit75","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2025"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0076|cit76","unstructured":"Higgins JP Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). Cochrane, 2011 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v5.1.0"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0077|cit77","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0078|cit78","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0079|cit79","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0080|cit80","doi-asserted-by":"crossref","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/www.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch12"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890.","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0082|cit82","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from https:\/\/gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0083|cit83","unstructured":"GRADEpro GDT GRADE Working Group, McMaster University 2025"},{"issue":"10","key":"10.1002\/14651858.CD003953.pub4-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/INF.0000000000001996","article-title":"A phase 3 study of micafungin versus amphotericin B deoxycholate in infants with invasive candidiasis","volume":"37","author":"Kaufman","year":"2018","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0085|cit85","unstructured":"A phase 3, randomized, double-blind, multi-center study to compare the efficacy and safety of micafungin versus amphotericin B deoxycholate for the treatment of neonatal candidiasis https:\/\/clinicaltrials.gov\/study\/NCT00815516"},{"issue":"1","key":"10.1002\/14651858.CD003953.pub4-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13052-025-01852-9","article-title":"Micafungin versus amphotericin B in treatment of invasive fungal infection in preterm neonates: a randomized control trial","volume":"51","author":"Ibrahim","year":"2025","journal-title":"Italian Journal of Pediatrics"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0087|cit87","unstructured":"Micafungin versus amphotercine B in treatment of invasive fungal infection https:\/\/clinicaltrials.gov\/study\/NCT06413056"},{"issue":"1","key":"10.1002\/14651858.CD003953.pub4-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/jac\/dkz398","article-title":"A randomized, double-blind trial investigating the efficacy of caspofungin versus amphotericin B deoxycholate in the treatment of invasive candidiasis in neonates and infants younger than 3 months of age","volume":"75","author":"Kim","year":"2020","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0089|cit89","unstructured":"Safety, tolerability, and efficacy of caspofungin versus amphotericin B deoxycholate in the treatment of invasive candidiasis in neonates and infants (MK-0991-064) https:\/\/clinicaltrials.gov\/show\/NCT01945281"},{"issue":"9","key":"10.1002\/14651858.CD003953.pub4-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/bcp.13628","article-title":"Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized, open-label clinical trial","volume":"84","author":"Leroux","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0091|cit91","unstructured":"Fluconazole versus micafungin in neonates with suspected or culture-proven candidiasis: a randomized pharmacokinetic and safety study (TINN Project - Treat Infections in Neonates) https:\/\/clinicaltrials.gov\/study\/NCT02145832"},{"issue":"1","key":"10.1002\/14651858.CD003953.pub4-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/tropej\/fmr025","article-title":"A randomized, double-blind, prospective study of caspofungin vs. amphotericin B for the treatment of invasive candidiasis in newborn infants","volume":"58","author":"Mohamed","year":"2012","journal-title":"Journal of Tropical Pediatrics"},{"issue":"12","key":"10.1002\/14651858.CD003953.pub4-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1097\/00006454-199612000-00011","article-title":"Fluconazole versus amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial","volume":"15","author":"Driessen","year":"1996","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD003953.pub4-BIB0094|cit94","unstructured":"World Bank Country and Lending Groups World Bank classification by income https:\/\/ddh-openapi.worldbank.org\/resources\/DR0095333\/download"},{"issue":"9","key":"10.1002\/14651858.CD003953.pub4-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/INF.0b013e31817275e6","article-title":"Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial","volume":"27","author":"Queiroz-Telles","year":"2008","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"6","key":"10.1002\/14651858.CD003953.pub4-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ijantimicag.2019.02.019","article-title":"Echinocandins vs. amphotericin B against invasive candidiasis in children and neonates: A meta-analysis of randomized controlled trials","volume":"53","author":"Chen","year":"2019","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"1","key":"10.1002\/14651858.CD003953.pub4-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/inf.0000000000002032","article-title":"Efficacy and safety of echinocandins for the treatment of invasive candidiasis in children: a meta-analysis","volume":"38","author":"Tsekoura","year":"2019","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"4","key":"10.1002\/14651858.CD003953.pub4-BIB0098|cit98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003953","article-title":"Systemic antifungal drugs for invasive fungal infection in preterm infants","author":"Clerihew","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:02:56Z","timestamp":1793786576000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003953.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":98,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003953.pub4","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}